Table 3 Clinical and pathological characteristics of the low-risk patients (n = 104)
Low-Risk Patients Analysis (n = 104) | ||
|---|---|---|
Age (yr) | Median (range) | 67.5 (55–77) |
PSA | Median (range) | 5.8 (2.78–9.7) |
PSAD | Median (range) | 0.16 (0.06–0.62) |
GGa | 1 (%) | 25 (24) |
2 (%) | 59 (57) | |
3 (%) | 16 (15) | |
4 (%) | 3 (3) | |
5 (%) | 1 (1) | |
LVI | Positive (%) | 11 (11) |
EPE | Positive (%) | 13 (13) |
SM | Positive (%) | 27 (26) |
SVI | Positive (%) | 0 (0) |
IDCP | Positive (%) | 10 (10) |
pT | 2 (%) | 91 (88) |
3a (%) | 13 (13) | |
Follow-up duration (mo) | Median (range) | 35.5 (0–109) |